Home Healthcare Pharmaceuticals Multiple Sclerosis Drugs Market

Multiple Sclerosis Drugs Market Size, Share & Trends Analysis Report By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Others), By Route of Administration (Oral, Injectables, Infusions), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Disease Type (Relapsing-remitting MS (RRMS), Primary-progressive MS (PPMS), Secondary-progressive MS (SPMS), Progressive-relapsing MS (PRMS)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR1412DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
  7. North America Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
  8. Europe Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    8. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
  9. APAC Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
    6. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    9. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
  10. Middle East and Africa Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
  11. LATAM Multiple Sclerosis Drugs Market Size Analysis
    1. Introduction
    2. Multiple Sclerosis Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Immunomodulators
      2. Immunosuppressants
      3. Interferons
      4. Others
    3. Multiple Sclerosis Drugs Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
        1. Intramuscular
        2. Subcutaneous
        3. Intravenous
      3. Infusions
    4. Multiple Sclerosis Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Stores
    5. Multiple Sclerosis Drugs Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Relapsing-remitting MS (RRMS)
      2. Primary-progressive MS (PPMS)
      3. Secondary-progressive MS (SPMS)
      4. Progressive-relapsing MS (PRMS)
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Immunomodulators
        2. Immunosuppressants
        3. Interferons
        4. Others
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
          1. Intramuscular
          2. Subcutaneous
          3. Intravenous
        3. Infusions
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Stores
      5. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Relapsing-remitting MS (RRMS)
        2. Primary-progressive MS (PPMS)
        3. Secondary-progressive MS (SPMS)
        4. Progressive-relapsing MS (PRMS)
  12. Competitive Landscape
    1. Multiple Sclerosis Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bayer AG
    3. Teva Pharmaceutical Industries Ltd.
    4. Novartis AG
    5. Sanofi
    6. F. Hoffmann-La Roche Ltd.
    7. Celgene Corporation
    8. Acorda Therapeutics Inc.
    9. Biogen Inc.
    10. Johnson & Johnson
    11. EMD Serono
    12. Eisai Co. Ltd.
    13. Apitope
    14. AbbVie Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.